PAG
AMPH icon

Private Advisor Group’s Amphastar Pharmaceuticals AMPH Stock Holding History

Private Advisor Group’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-354
Closed -$8K – 1637
2020
Q2 		$8K Buy
+354
New +$6.48K ﹤0.01% 3011

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Private Advisor Group's AMPH Position: Q3 2020 in Review

Private Advisor Group sold out of Amphastar Pharmaceuticals (AMPH) in Q3 2020, closing a stake of 354 shares — an estimated $8K sold.

Private Advisor Group first reported a position in AMPH in Q2 2020 and held it in 1 quarter. The position peaked at $8K in Q2 2020. 136 funds tracked by Wall St. Rank hold AMPH as of Q3 2020.

  • Private Advisor Group reported no remaining Amphastar Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 354 Amphastar Pharmaceuticals shares in Q3 2020, an estimated $8K.
  • Private Advisor Group first reported a position in Amphastar Pharmaceuticals in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Amphastar Pharmaceuticals position peaked at $8K in Q2 2020.
  • 136 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.